Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma

adriamycin: 9mg/m² intravenous (IV) push on days 1 to 4

bortezomib: 1.3 mg/m² intravenous (IV) bolus on days 1, 4, 8, and 11

dexamethasone: 40 mg daily days 1- 4/9-12/17-20 - cycle 1 / days 1-4/17-20 - subsequent cycle

vincristine: 0.4mg IV push on days 1 to 4